MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
VolitionRx Limited EV - Enterprise Value 2011-2026 | VNRX
Annual EV - Enterprise Value VolitionRx Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 87 M | 74.1 M | 99.7 M | 146 M | 181 M | 175 M | 71.6 M | 87.2 M | 88.8 M | 62.6 M | 68.1 M | 27.6 M | 24.4 M | -218 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 181 M | -218 K | 85.2 M |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Anixa Biosciences
ANIX
|
990 K | $ 2.85 | -3.72 % | $ 92.5 K |  USA |
 |
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
45.8 B | $ 118.6 | 0.4 % | $ 36.1 B | USA |
 |
Celcuity
CELC
|
506 M | $ 107.62 | -0.63 % | $ 4.25 B | USA |
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Castle Biosciences
CSTL
|
665 M | $ 27.55 | -1.59 % | $ 765 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M |  Britain |
 |
Charles River Laboratories International
CRL
|
11.4 B | $ 175.77 | -1.61 % | $ 8.71 B | USA |
 |
Fulgent Genetics
FLGT
|
502 M | $ 13.82 | -2.68 % | $ 418 M | USA |
 |
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | USA |
|
Biodesix
BDSX
|
142 M | $ 15.5 | -1.59 % | $ 2.01 B | USA |
 |
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
35.7 M | $ 1.12 | -1.78 % | $ 1.42 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 208.28 | -0.95 % | $ 23.1 B | USA |
 |
Danaher Corporation
DHR
|
145 B | $ 204.04 | -0.9 % | $ 145 B | USA |
 |
Exact Sciences Corporation
EXAS
|
22 B | $ 103.38 | 0.02 % | $ 19.5 B | USA |
 |
Bioventus
BVS
|
904 M | $ 8.8 | 0.34 % | $ 551 M | USA |
 |
DarioHealth Corp.
DRIO
|
6.61 M | $ 10.3 | -4.19 % | $ 292 M |  Israel |
 |
DexCom
DXCM
|
28.2 B | $ 73.0 | -1.06 % | $ 28.5 B | USA |
 |
ICON Public Limited Company
ICLR
|
26.4 B | $ 108.44 | 0.16 % | $ 8.94 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
52.7 B | $ 635.29 | -0.22 % | $ 51.1 B | USA |
 |
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B |  Niderland |
 |
Burning Rock Biotech Limited
BNR
|
433 M | $ 24.01 | -4.59 % | $ 254 M | China |
 |
Illumina
ILMN
|
15.3 B | $ 129.9 | -2.25 % | $ 20.7 B | USA |
 |
CareDx, Inc
CDNA
|
1.04 B | $ 18.74 | -0.03 % | $ 999 M | USA |
 |
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | Israel |
 |
Guardant Health
GH
|
15.2 B | $ 93.21 | 1.06 % | $ 11.7 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 283.19 | -1.07 % | $ 23.6 B | USA |
 |
Lantheus Holdings
LNTH
|
5.9 B | $ 79.15 | 3.74 % | $ 5.34 B | USA |
 |
IQVIA Holdings
IQV
|
49.6 B | $ 174.33 | 0.03 % | $ 30 B | USA |
 |
Brainsway Ltd.
BWAY
|
223 M | $ 23.2 | -2.09 % | $ 99.4 M | Israel |
 |
Co-Diagnostics
CODX
|
29.3 M | - | - | $ 79.8 M | USA |
 |
Mettler-Toledo International
MTD
|
32.1 B | $ 1 315.61 | -0.56 % | $ 27.1 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
598 M | $ 5.26 | 4.89 % | $ 487 M | USA |
 |
NeoGenomics
NEO
|
1.85 B | $ 9.53 | 0.26 % | $ 1.22 B | USA |
 |
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Natera
NTRA
|
5.53 B | $ 206.39 | 3.11 % | $ 20.3 B | USA |
 |
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
Pacific Biosciences of California
PACB
|
1.21 B | $ 1.51 | -7.1 % | $ 453 M | USA |
 |
Neogen Corporation
NEOG
|
2.26 B | $ 10.93 | -1.97 % | $ 2.37 B | USA |
 |
Precipio
PRPO
|
10.9 M | $ 24.78 | 0.38 % | $ 32.2 M | USA |
 |
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | USA |